Bioniche Pharma Wrongly Guarantees Safety Of Sotradecol, Ad Division Warning Letter Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A company brochure for the varicose vein therapy implies FDA approval “guarantees” safety.
You may also be interested in...
AngioDynamics Foresees New Laser Sales Opportunities With Sotradecol
Angiodynamics will market its Sotradecol drug for the treatment of small, uncomplicated varicose veins with its VenaCure laser ablation system for larger varicose veins.
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue
FDA’s Arcoxia Decision Offers New Evidence Of Conservative Review Stance
FDA's "not approvable" action on Merck's Vioxx follow-on Arcoxia for the treatment of symptoms of osteoarthritis could be indicative of a conservative regulatory climate at the agency